riluzole has been researched along with Lung Neoplasms in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wangpaichitr, M | 1 |
| Wu, C | 1 |
| Li, YY | 1 |
| Nguyen, DJM | 1 |
| Kandemir, H | 1 |
| Shah, S | 1 |
| Chen, S | 1 |
| Feun, LG | 1 |
| Prince, JS | 1 |
| Kuo, MT | 1 |
| Savaraj, N | 1 |
1 other study available for riluzole and Lung Neoplasms
| Article | Year |
|---|---|
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Disease Models, Animal; | 2017 |